Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07279350 · ClinicalTrials.gov registry record · NA
Health Advocate for Children After Liver Transplant
A NA study, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT07279350 is a NA study that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 108 participants.
The verdict
NCT07279350, a NA study, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
The HEAL-Tx is a 90-day intervention, in which a Health Advocate works with eligible families to identify and apply for community-based resources, alert healthcare providers to challenges the family is encountering, and guide health system navigation (e.g., coordinating appointments). Families in the control arm will receive a printed handout that provides contact information for local community-based resources. Families in the treatment arm will receive HEAL-Tx.
Interventions
- BEHAVIORAL Enhanced Control
- BEHAVIORAL Health advocate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2026-05-05 |
| Est. Completion | 2030-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07279350
The ClinicalTrials.gov registry entry for NCT07279350 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Control is the first listed.
NCT07279350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07279350 about?
NCT07279350 is a clinical study titled "Health Advocate for Children After Liver Transplant". The HEAL-Tx is a 90-day intervention, in which a Health Advocate works with eligible families to identify and apply for community-based resources, alert healthcare providers to challenges the family is encountering, and guide health system navigation (e.g., coordinating appointments). Families in th...
What is the current status of trial NCT07279350?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2026-05-05. Estimated completion is 2030-08-01.
What interventions are being tested in trial NCT07279350?
The interventions under investigation include: Enhanced Control (BEHAVIORAL), Health advocate (BEHAVIORAL).
Who is sponsoring clinical trial NCT07279350?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.